Label: VIR COMBINATION (influenzinum- 2021-2022, herpes simplex 1 nosode, herpes simplex 2 nosode, human herpesvirus 6a, human herpesvirus 6b, cytomegalovirus nosode, hepatitis b nosode, adenoviren nosode, epstein-barr virus nosode liquid

  • NDC Code(s): 43742-2040-1
  • Packager: Deseret Biologicals, Inc.
  • Category: HUMAN OTC DRUG LABEL

DISCLAIMER: This homeopathic product has not been evaluated by the Food and Drug Administration for safety or efficacy. FDA is not aware of scientific evidence to support homeopathy as effective.

Drug Label Information

Updated December 7, 2022

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

View All Sections
  • ACTIVE INGREDIENTS:

    Influenzinum (2021-2022) 12X, 15X, 30X, 60X, 200X, Herpes Simplex 1 15X, 30X, 60X, 200X, Herpes Simplex 2 15X, 30X, 60X, 200X, Human Herpesvirus 6A 15X, 30X, 60X, 200X, Human Herpesvirus 6B 15X, 30X, 60X, 200X, Cytomegalovirus Nosode 18X, 30X, 60X, 200X, Hepatitis B Nosode 33X, 60X, 200X, Adenoviren Nosode 12C, 30C, 60C 200C, Epstein-Barr Virus Nosode 16C, 30C, 60C, 200C

  • HOMEOPATHIC INDICATIONS:

    For temporary relief of symptoms related to general viral infection, including fever, fatigue, muscle aches and pain, rash, cold sores, headache and confusion.**

    **These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.

  • WARNINGS:

    Keep out of reach of children. In case of overdose, contact a physician or Poison Control Center right away.

    If pregnant or breast-feeding, ask a health professional before use.

    Tamper seal: "Sealed for Your Protection." Do not use if seal is broken or missing.

  • KEEP OUT OF REACH OF CHILDREN:

    Keep out of reach of children. In case of overdose, contact a physician or Poison Control Center right away.

  • DIRECTIONS:

    1-10 drops under the tongue, 3 times a day or as directed by a health professional. Consult a physician for use in children under 12 years of age.

  • DIRECTIONS:

    1-10 drops under the tongue, 3 times a day or as directed by a health professional. Consult a physician for use in children under 12 years of age.

  • INACTIVE INGREDIENTS:

    Demineralized Water, 25% Ethanol

  • QUESTIONS:

    Dist. By: Deseret Biologicals, Inc.

    469 W. Parkland Drive

    Sandy, UT 84070 www.desbio.com

  • PACKAGE LABEL DISPLAY:

    DESBIO

    NDC 43742-2040-1

    HOMEOPATHIC

    VIR:COMBINATION

    1 FL OZ (30 ml)

    VIR:COMBINATION

  • INGREDIENTS AND APPEARANCE
    VIR COMBINATION 
    influenzinum (2021-2022), herpes simplex 1 nosode, herpes simplex 2 nosode, human herpesvirus 6a, human herpesvirus 6b, cytomegalovirus nosode, hepatitis b nosode, adenoviren nosode, epstein-barr virus nosode liquid
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:43742-2040
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED) (UNII: WD5E5VYM2E) (INFLUENZA A VIRUS A/VICTORIA/361/2011 IVR-165 (H3N2) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED) - UNII:W762BRG698) INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED)12 [hp_X]  in 1 mL
    INFLUENZA A VIRUS A/TASMANIA/503/2020 IVR-221 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED) (UNII: V529EJB2CX) (INFLUENZA A VIRUS A/TASMANIA/503/2020 IVR-221 (H3N2) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED) - UNII:CYN792B8TR) INFLUENZA A VIRUS A/TASMANIA/503/2020 IVR-221 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED)12 [hp_X]  in 1 mL
    INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED) (UNII: VEH9U90EHX) (INFLUENZA B VIRUS B/WASHINGTON/02/2019 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED) - UNII:1G2CU2LIB5) INFLUENZA B VIRUS B/WASHINGTON/02/2019 ANTIGEN (FORMALDEHYDE INACTIVATED)12 [hp_X]  in 1 mL
    INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED) (UNII: B93BQX9789) (INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED) - UNII:9HB0XUS9TM) INFLUENZA B VIRUS B/PHUKET/3073/2013 ANTIGEN (FORMALDEHYDE INACTIVATED)12 [hp_X]  in 1 mL
    HUMAN HERPESVIRUS 1 (UNII: 22G38P19RL) (HUMAN HERPESVIRUS 1 - UNII:22G38P19RL) HUMAN HERPESVIRUS 115 [hp_X]  in 1 mL
    HUMAN HERPESVIRUS 2 (UNII: 74J6DNH49U) (HUMAN HERPESVIRUS 2 - UNII:74J6DNH49U) HUMAN HERPESVIRUS 215 [hp_X]  in 1 mL
    HUMAN HERPESVIRUS 6 (UNII: 4IX4VP35CR) (HUMAN HERPESVIRUS 6 - UNII:4IX4VP35CR) HUMAN HERPESVIRUS 615 [hp_X]  in 1 mL
    HUMAN HERPESVIRUS 5 (UNII: 7COI029E6K) (HUMAN HERPESVIRUS 5 - UNII:7COI029E6K) HUMAN HERPESVIRUS 518 [hp_X]  in 1 mL
    HEPATITIS B VIRUS (UNII: 77H9EM77P7) (HEPATITIS B VIRUS - UNII:77H9EM77P7) HEPATITIS B VIRUS33 [hp_X]  in 1 mL
    HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN (UNII: FKD3DUK39I) (HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 - UNII:FKD3DUK39I) HUMAN ADENOVIRUS E SEROTYPE 4 STRAIN CL-68578 ANTIGEN12 [hp_C]  in 1 mL
    HUMAN ADENOVIRUS B SEROTYPE 7 STRAIN 55142 ANTIGEN (UNII: TM54L796SN) (HUMAN ADENOVIRUS B SEROTYPE 7 STRAIN 55142 ANTIGEN - UNII:TM54L796SN) HUMAN ADENOVIRUS B SEROTYPE 7 STRAIN 55142 ANTIGEN12 [hp_C]  in 1 mL
    HUMAN HERPESVIRUS 4 (UNII: 2A26YW7PNX) (HUMAN HERPESVIRUS 4 - UNII:2A26YW7PNX) HUMAN HERPESVIRUS 416 [hp_C]  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    WATER (UNII: 059QF0KO0R)  
    ALCOHOL (UNII: 3K9958V90M)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:43742-2040-130 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product02/02/202208/23/2027
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved homeopathic02/02/202208/23/2027
    Labeler - Deseret Biologicals, Inc. (940741853)
    Registrant - Apotheca Company (844330915)
    Establishment
    NameAddressID/FEIBusiness Operations
    Apotheca Company844330915manufacture(43742-2040) , api manufacture(43742-2040) , label(43742-2040) , pack(43742-2040)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials

More Info on this Drug

Get Label RSS Feed, View NDC Code(s)NEW!